Puma Biotechnology | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Exelixis USD 579.18M 30.39M 2025-09
Gilead Sciences USD 6.2B 620M 2025-09
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Incyte USD 1.39B 118.68M 2025-12
MacroGenics USD 61.25M 88.71M 2025-09
Moderna USD 809M 791M 2025-09
Novartis USD 10.82B 695M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 187.69M 24.3M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Takeda JPY 790.55B 262.97B 2025-12
TG Therapeutics USD 133.62M 11.41M 2025-09
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09


Puma Biotechnology Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.